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Aneurysmal disease is the 13th leading cause of death in the
United States, and the incidence of the disease is increasing
annually.

The etiology of abdominal aortic aneurysms (AAA) is

presently unknown, and several theories have been advanced in
recent years.

A 'minimum' requirement for a working hypothesis is

that it should explain two important observations: 1) There is
increased proteolysis of the aorta (which may be due to increased
protease activity or decreased antiprotease activity); and 2) There
is a strong familial predisposition, with 20-30% of first-degree
relatives of patients with AAA also affected.
among AAA patients has also been noted.

A male predominence

Tissue Inhibitor of

MetalloProteases (TIMP) is a major antiprotease of connective
tissue and its gene has been assigned to the X chromosome.

Factors

causing relative deficiency of this inhibitor could account for
increased proteolysis and explain genetic features of the disease.
Previous work suggests that TIMP is deficient in AAA aorta.

.

Experiments were performed to determine if deficiency of
TIMP is due to mutation resulting in decreased expression or an
altered gene product.

Northern blots of RNA from dermal fibroblast

cultures isolated from AAA patients were probed with human TIMP
cDNA generated by polymerase chain reaction (PCR).

Human TIMP

cDNA generated from the isolated RNA in one patient was also
sequenced.

Dermal fibroblasts expressed TIMP mRNA in all cell lines

and there was no significant difference in TIMP expression in six
patients vs two controls.

There was a normal nucleotide sequence

of the cDNA.
These studies do not support the hypothesis that deficiency of
TIMP in AAA tissue is due to a primary defect in the gene.
Deficiency of TIMP may be due to decreased expression or binding
under local conditions in the aneurysmal aorta or due to increased
degradation.

Further studies to rule out expression abnormalities in

aortic smooth muscle cells and macrophages in AAA may be useful,
since the present studies were based on dermal fibroblasts.
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Introduction

Aneurysms are described as local irreversible dilatation or
outpouching of arterial walls with at least a 50% increase in diameter
compared to the expected normal diameter [1,2].

They result in

deterioration and destruction of the architecture of the arterial walls,
resulting in loss of elastin and smooth muscle cells [3].

The

abdominal aorta is the most common site of aneurysms in the aorta,
and these are of two types, fusiform and saccular.

Fusiform

aneurysms are most common, and are cylindrical, involving the
entire circumference of the aorta in the wall of the aneurysm.
Saccular aneurysms, on the other hand, are rare and incorporate only
a portion of the aortic wall into the wall of the aneurysm.

As its

name implies, this aneurysm is a sac-like protrusion from the aorta.
[4].

Aneurysmal disease ranks 13th as a leading cause of death in

the United States [5], and a recent epidemiological study reported
that the apparent incidence of abdominal aortic aneurysms (AAA)
has increased seven-fold between 1951 and 1980 [6].

Another study

showed that 5% of the U.S. population over 60 years old have
aneurysmal dilatation of the abdominal aorta, with an increase in
incidence of new AAA of 8.7/100000 from 1950 - 60, to
36.5/100000 from

1971-80

[7].

Rupture of AAA is a life-threatening occurrence.

Discovered

before rupture, successful management can lead to long term
survival with operative motality less than 5%.

However, if rupture

occurs, the mortality increases to greater than 50%. [8,9].

Studies

show that the 5 year risk of rupture is less than 15% in AAA up to 4

-
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cm in diameter, and increases with increasing size of AAA to more
than 75% at 8 cm.

The rate of enlargement of AAA is approximately

0.4 cm per year. [7].

Identification of risk factors for AAA might

permit early intervention for prevention and/or discovery of early
asymptomatic lesions, amenable to elective repair.

This would lead

to decreased chance of rupture, and improve long term prognosis.
Unfortunately, few factors predictive of the presence of AAA have
been identified to date.

In humans, AAA is predominantly a disease

of elderly males [10], and population studies indicate that smoking,
hypertension, and diet are important risk factors for development of
these lesions [11].

However, screening a hypertensive population for

AAA revealed aortic dilatation in only one of 245 patients [12].

It is

known that certain strains of turkeys develop aortic aneurysms in
males, associated with hypertension and abnormally increased levels
of serum lipids, which are genetically determined in these species
[13,14].

A better understanding of the etiology of AAA disease is,

therefore, essential to more effective management of this disorder.
The etiology of AAA has met with some controversy.

Until

recently, atherosclerosis was considered to be the major etiologic
agent for aneurysms, accounting for about 96%, with trauma,
syphilitic aortitis, infectious agents (bacteria, fungi, mycobacteria),
degenerative conditions (Marfan's

syndrome, Ehlers-Danlos

syndrome, and cystic medial necrosis), collagen-vascular diseases,
various vasculitidies, and congenital anomalies indicted in causing
the remainder [2].

However, the atherosclerosis theory has been

challenged because with experimental atherosclerosis, there has only
been one aneurysm reported in dogs [15], and a single fusiform

-
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aortic aneurysm among 730 squirrel monkeys [16], suggesting that
atherosclerosis does not usually induce aneurysmal disease.

Other

observations which do not support the atherosclerosis theory are the
rarity of aneurysmal development in aortas severely involved with
atherosclerosis, and the infrequency of distal occlusive
atherosclerotic lesions in patients with AAA [4].

Also, it has been

shown that there are differences in the population characteristics,
such as age, height, weight, sex, mortality and subsequent operative
therapy, between patients with AAA and those with atherosclerotic
occlusive disease, suggesting that there are differences in the
underlying pathological processes [10].

This information has led

many investigators to propose several hypotheses to explain
aneurysmal

Proteolysis

development.

hypothesis

The aorta is composed of elastin, arranged in the media in a
concentric manner, a reticular network of type I and type III
collagen fibers, and layers of smooth muscle cells.

It was suggested

that aneurysms may be secondary to a proteolytic process, since in
aneurysmal aorta, elastin and collagen content is decreased, and
there is increased collagenase and elastase activity, compared to
normal aortas. [4].

Sumner et al [17] observed that the % collagen

and % elastin in AAA is much less than in nonaneurysmal
atherosclerotic aorta, and suggested that this is a reflection of the
degenerative process involving the AAA wall.

Collagen and elastin

were more concentrated in the outer layer of the AAA.

Many other

investigators have defined proteolytic features of AAA disease, both

4

in serum and in tissue [18-21]. The deficit of collagen may be a
precipitating cause of aneurysm formation and expansion.

Dobrin et

al [22] found that treatment of arteries with elastase resulted in
dilatation, but remained intact; whereas treatment with collagenase
resulted

in rupture.

Busuttil et al [21] found that collagenase activity was
detectable in the AAA, but not in atherosclerotic aorta, and
collagenase activity correlated with aneurysm size.

They

hypothesized that endogenous collagenolytic activity may be
responsible for aneurysmal expansion and rupture, and that the
enzyme is localized in AAA wall and inoperative in atherosclerotic
arteries.
size.

The degree of collagen breakdown correlates with AAA

This collagenase-like activity may account for the decreased

collagen found by Sumner et al in AAA tissue, and the relative
absence of collagenase activity in atherosclerotic aorta could explain
the greater content of collagen observed in this tissue.

Measured

collagenase activity is greater in the inner layer than in the outer
layer, which would support Sumner's observation of more collagen in
the outer layer.
Busuttil et al [23] also noted that elastase activity was
increased in AAA, compared to atherosclerosis, while Cohen et al [19]
demonstrated that aortic elastase was significantly higher in patients
with AAA, compared to patients with occlusive aortic disease.

These

findings support the theory that aneurysm formation is secondary to
a proteolytic process.

Elastin content of aneurysmal aortic media is

8.1%; normal aortic media is 35%; and atherosclerotic aortic media is
22% [24].

The absence of collagenolytic and elastolytic activity in

■
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atherosclerotic aorta not affected by aneurysmal change, points to
the different pathogenesis between these 2 lesions [21].
The possibility of failure of a protease/antiprotease balance
was suggested by Cannon and Read in 1982 [18].

Serum elastolytic

activity and leucocyte elastolytic activity are significantly increased,
with decreased antiproteolytic activity in AAA patients.

One

explanation of this would be that aneurysm of the aorta is associated
with deficiency of antiprotease content.

However, this condition has

been reported only as a congenital defect by Eriksson [25], looking at
protease and protease inhibition in chronic obstructive pulmonary
disease (COPD).

Another possibility is that even though the

concentration and phenotype of alphaj-protease inhibitor is normal,
its antiproteolytic capacity is not.

This has been described by many

investigators in cigarette smokers with and without emphysema [2628].

Smoking is known to alter elastase/antiprotease balance in the

lung, leading to emphysema [18,29].

Emphysema is thought to be

secondary to proteolysis of the extracellular matrix of the lungs by
macrophage elastases, which are inhibited by alpha1-antitrypsin

in

normal lung tissue [30-33].
Experiments by Cohen et al [19] support the
protease/antiprotease imbalance theory, in

that, comparing tissue

from patients who underwent an operation on the abdominal aorta
for ruptured AAA, an elective procedure for AAA, or aortofemoral
bypass for occlusive disease, patients with ruptured AAA had the
highest elastase activity, and the lowest alphaj -antitrypsin.
suggests that the homeostatic balance between elastase and

This

-

6

antiprotease may be significantly altered in the aortic wall, especially
at the time of aortic rupture.
The proteolysis seen in AAA disease may not only be caused
by an imbalance in elastase/alpha1-antitrypsin, but by other
proteases not inhibited by alpha1-antitrypsin.

Campa et al [24]

report evidence of a metalloprotease which degrades elastin.

They

observed increased elastinolytic activity in AAA, predominantly
secondary to a protease which hydrolyzed elastin, but is not
inhibited by alphaj-antitrypsin or chloromethyl ketone, and has no
immunological cross-reactivity with leucocyte elastase, which is a
serine protease.

This protease is inhibited by EDTA.

Of note, there

are only trivial amounts in atherosclerotic aorta, and none in normal
aorta.

Brown et al [20] and Reilly et al [34] have identified an

elastolytic activity in AAA patients, with the inhibitory profile of a
metalloelastase, which causes elastin degradation in normal aorta.
This substance is not circulating elastase, and may originate from
arterial aneurysmal tissue.

It has affinity for aneurysm wall, is

increased in patients with AAA, and is inhibited by copper.

A

similar metalloelastase has been isolated from macrophages in lung
tissue [33], leading to the hypothesis that macrophages, present in
the inflammatory infiltrate in AAA, release metalloelastases which
are uninhibited by circulating antiproteases, resulting in the
increased proteolytic activity observed in AAA disease [35].

Thus,

the presence of increased proteolysis in AAA tissue is due to either
an increase in the activity of proteases or a decrease in inhibitory
activity [36].

-
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Biomechanical/phvsiological

hypothesis

The abdominal aortic segment below the level of the renal
outflow is particularly prone to the formation of both true
aneurysms and atherosclerotic occlusive disease.

Special local factors

in the abdominal segment of the aorta in certain individuals may be
of great importance in predisposing to the development of
aneurysmal disease. [2].

Elastin content of aortic media decreases

down the aorta from 50% in the thoracic aorta [24] to 24% in the
infrarenal aorta [37].

Aneurysms develop in the region of the aorta

with decreasing elastin content [24].

Also, smooth muscle cells in the

infrarenal aorta have decreased replication potential in culture
compared to thoracic aortic smooth muscle cells [3].

This limited

ability to regenerate could account for the loss of architecture of the
infrarenal aorta, resulting in aneurysm formation.
The aortic media is normally nourished by diffusion from the
endothelial surface and by vasa vasorum, which penetrate into the
media from the adventitial side.

Diffusion from the lumen is

sufficient to nourish the inner 0.5 mm of medial thickness.

This zone

contains no vasa vasorum and encompasses about 30 medial
fibrocellular layers.

Species with more than 30 medial layers have

vasa vasorum beyond the 30th layer.

The presence of medial vasa

vasorum permits the medial layers to function at a higher level of
medial stress, and, in large animals, the avascular inner zone
maintains its orderly lamellar arrangement, while the outer
vascularized zone may deviate somewhat from the usual architecture
as the animal increases in size.

Between the renal arteries and the

aortic bifurcation, the adult human aorta is about 0.7 mm in

'
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thickness.

For mammals, in general, this thickness would be

expected to include an outer vascularized zone of about 10 layers.
The human abdominal aorta has 29 layers, and is devoid of medial
vasa vasorum. [2].
The infrarenal abdominal aorta is a site at which medial tensile
stresses are relatively elevated, and where the media is
comparatively thin.

Depending upon conditions, this location may be

vulnerable to aneurysm formation.

Transmission of flowing blood

through a junction is dependent on the junctional cross-sectional area
ratio (ratio of the sum of the cross-sectional areas of the branch
vessels to that of the vessel of origin).

There is minimal reflection of

the pressure pulse with a cross-sectional area ratio in the range of
1.15 to 1.26 for a two-vessel branch.

This is referred to as 'matched'.

In most species, the infrarenal aorta to the common iliac system is
matched with values greater than 1.15; however, humans are
unmatched even at infancy with a value of 1.11.

This value

continues to decrease, averaging about 0.75 at age 50, contributing to
continuous detrimental effects on the hemodynamics of the
infrarenal aorta, and resulting in increased pulsatile reflections and
increased lateral pressure.

These effects are worsened in the

presence of dilatation and aneurysm.
Measurements of elasticity and deformation indicate that the distal
portion of the infrarenal aorta is the stiffest portion of the abdominal
aorta, and is the primary site for receiving deleterious effects from
dynamic disturbances of pulsatile reflection and lateral pressure. [2]

9

Genetic/environmental

hypothesis

There is evidence to suggest that aneurysms can be inherited
in both 'mice and men'.

Mice with certain alleles for coat color at the

X chromosome locus, Mottled, have connective tissue abnormalities,
which result in aortic aneurysms, and decreased tensile strength of
skin [38-40].

These abnormalities in Blotchy mouse are a result of

impaired formation of cross-links of collagen and elastin, secondary
to failure to generate lysine-derived aldehydes required for crosslinking.

The mutation affects copper metabolism [41,42], and since

copper is a cofactor for lysyl oxidase [38] (the enzyme which
converts lysine residues to aldehydes), it is likely that this copper
deficiency results in inactivation of the enzyme, leading to increased
collagen and elastin solubility.

This pathogenesis coincides with that

of aneurysms produced in turkeys [43,45] and rats [46] by
administration of lathyrogens, such as 15 -aminoproprionitrile

(BAPN),

which inactivate lysyl oxidase, resulting in decreased formation of
lysine-derived aldehydes [2,4,43,44].

Copper deficiency has also

been reported to produce aneurysms in poultry [47] and pigs [48].
In humans, there is familial tendency to AAA, suggesting a
genetic etiology.

A Swedish study reported that 18% of patients with

AAA had at least one relative with AAA disease [49].

These findings

were confirmed in a study of 250 patients with AAA, and 250
controls, where 19.2% of the patients with AAA had a first-degree
relative with AAA, compared with 2.4% of the control subjects [50].
Two recent screening studies show that up to 29% of brothers of
patients with AAA also have aortic dilatation or aneuryms [51,52].
Tilson & Seashore [53], in a study of 50 families with AAA in two or

■S
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more first-order relatives, observed that the number of men with
AAA exceeded the number of women by ratios as high as 8:1.
Bengtsson [51] also noted a male preponderance in AAA disease with
29% of brothers of patients with AAA also having aortic dilatation
compared to 6% of sisters.

These findings suggest an X-linked

inheritance which would correspond to the Blotchy mouse model,
where a known mutation on the X chromosome (affecting copper
metabolism), predisposes to development of spontaneous aortic
aneurysms.

It is interesting that the AAA-specific elastase isolated

by Brown [20] is inhibited by copper, and Tilson [54] documented
decreased tissue copper levels in both experimental animals and
patients with AAA.
Other evidence suggestive of a genetic predisposition to AAA
includes the observations by Tilson & Dang [55] that patients with
AAA tend to be taller, have a greater mean body surface area, and
have generalized arteriomegally.

Also, AAA disease has been

reported in identical twins [56].

Defects in collagen genes can

account for some forms of aneurysmal disease [3].

A mutation in the

gene for type III collagen in Ehlers-Danlos Type IV leads to thin skin
and sudden rupture of large blood vessels.

Also, a mutation in pro-

alpha-2 gene for type I procollagen found in individuals with Marfan
phenotype leads to sudden rupture of the aorta [57].

Kontusaari et

al [58] report the development of aortic aneurysms in a family
caused by a single base mutation in type III procollagen gene.

A

single base mutation of glycine 619 of alphaj (III) chain to a codon
for arginine resulted in synthesis of procollagen which undergoes

-

thermal unfolding at a lower temperature, leading to mild bleeding
tendencies and aortic

aneurysm formation.

Powell et al [59] have suggested that a gene on chromosome 16
is associated with AAA.

Investigation of polymorphic serum

markers show an increased frequency of the haptoglobin alpha1 gene
in patients with aneurysms [60].

The haptoglobin gene is located on

the long arm of chromosome 16, close to 2 genes coding for proteins
involved in lipid metabolism; lethicin : cholesterol acyl transferase
(LCAT) and cholesterol ester transfer protein (CETP).

CETP is

polymorphic, and the frequency of rare polymorphisms at the CETP
locus is increased in AAA patients.

Haptoglobin functions by binding

hemoglobin and transporting it to the liver during hemolysis.
Haptoglobins containing the alphaj chain accelerated the degradation
of aortic elastin by elastases in vitro
by binding to elastin.

by two- to four-fold, probably

They concluded that genetic variation in

haptoglobin and CETP genes appears to influence dilatation of the
abdominal aorta.

Also, variation at the haptoglobin locus has a direct

effect on elastin degradation, and CETP variation could affect lipid
metabolism and promote atherosclerosis. Thus, they suggested that a
gene on chromosome 16 is associated with AAA, although this may
be an as yet unidentified gene in linkage equilibrium with the
haptoglobin and CETP genes.

An autosomal pattern of inheritance for

some AAA disease would be consistent with earlier reports by Tilson
& Seashore [53] that 12 of 50 families with AAA had father to son
transmission, suggesting an autosomal dominant pattern of
inheritance.

12

TIMP

hypothesis
Proteolysis, coupled with the biomechanical and physiological

properties of the abdominal aorta, can account for AAA development,
but do not explain the selective increase in AAA disease seen in
relatives of patients with AAAs.

The relative risk to brothers and

sisters of patients with AAA is significantly greater than 1 indicating
that familial factors are important in the etiology of AAA [61].

It

appears that the etiology of AAA is related to a mechanism that links
the proteolytic and genetic phenomena observed in AAA disease.
Assignment of a gene coding for a Tissue Inhibitor of
Metalloproteases (TIMP) to the X chromosome

raises the possibility

that a relative deficiency of this factor might be the link between
proteolytic and genetic phenomena [62,63].

TIMP is a molecule of

28.5 kDa that has been implicated as a tissue inhibitor of collagenase,
gelatinase, proteoglycanase, and other metalloproteases

[33,64,65].

It was localized to the X chromosome from Xp 11.1 to Xp 11.4 by in
situ hybridization [62].

As stated earlier, there is evidence to suggest

X-linked inheritance of AAA disease, with the number of men with
AAA exceeding the number of women by ratios as high as 8:1 [53].
The presence of an inhibitor of metalloelastase on the X chromosome
suggests that predisposition to a relative deficiency of TIMP could
result in a protease/antiprotease imbalance, leading to proteolysis
and AAA, predominantly in males.

If this predisposition is

detectable by restriction fragment length polymorphisms (RFLPs) in
patients with AAA, it would be possible to screen high risk
populations, leading to early intervention in AAA disease.

Durphy et

al [66] reported that Bglll identifies a two allele polymorphism in the

■

human TIMP gene.

The frequency of the 12 kb allele is .66, and the

9.5/2.5 kb allele is .34.

Recent studies by Reilly & Tilson [personal

communication] show that the size and frequency of these alleles are
the same in patients with AAAs.
TIMP can be relatively deficient in tissue if it is defective,
down-regulated, or inactivated.

There are reports of low levels of

TIMP and increased protease activity in bone cultures induced to
undergo resorption [67], and in rabbit synovium cultures taken from
arthritic rabbits [68].

Also, there is evidence that TIMP serves to

regulate collagenase activity during collagen turnover in many
connective tissues throughout the body [69].

Brophy et al [70] show

that there is decreased TIMP in the aortas of patients with AAAs,
measured by Western blot and radioimmunoassay.

These findings

support the TIMP hypothesis as the unifying theory between
proteolysis and sex-limitation in AAA disease.
The purpose of this investigation is to: 1) look at expression of
TIMP in different cell types, 2) sequence the TIMP gene from
patients with AAA, and 3) evaluate expression of the TIMP gene in
patients with AAA, compared to controls.

It would be useful to

identify a genetic marker such as a mutation in the TIMP gene or a
regulatory defect which can be used to develop simple, cost-effective
screening tests so that individuals at high risk for AAA disease can
be easily identified, even prior to aneurysm development.

It is

encouraging to note that the mutation reported by Kontusaari, which
predisposes to some aortic aneurysms, can be detected in DNA from
saliva [58].

1 4

1) Edwards et al [71] reported that exposure of quiescent human
fetal lung fibroblasts to growth factors in the presence of
Transformation Growth Factor-G

(TGF-G)

resulted in inhibition of

collagenase induction, and a synergistic increase in TIMP expression.
Experiments were performed to examine the effect of TGF-G on TIMP
expression in fibroblasts, smooth muscle cells, and aortic endothelial
cells, in an effort to extrapolate Edwards' findings to cells more likely
to be involved in aneurysm development.
2) A relative deficiency of TIMP could be secondary to a mutation in
the TIMP gene, resulting in a defective product, which is unable to
inhibit elastin degradation.

The TIMP gene from patients with AAA

was sequenced and compared with the normal sequence [72].
3. Down-regulation of the TIMP gene could result in decreased
transcription, resulting in decreased levels of TIMP and increased
proteolysis.

Reports that TIMP is decreased in patients with AAA

support this hypothesis [70].

Experiments were performed to

compare TIMP expression in patients with AAA and patients without
AAA.

1 5

Materials

and

Methods

TIMP expression in various cell types
Total RNA from rat fibroblast and smooth muscle cells, and
bovine aortic endothelial cells was obtained from Dr. Olivier Kocher
in Dr. J. Madri's laboratory (Department of Pathology, Yale
University).
(TGF-B).

Cells were treated with transforming growth factor-13
Untreated cells were used as controls.

10 micrograms (pg )

of total RNA was electrophoresed in a 1.2% agarose gel containing
formaldehyde as described in Sambrook et al [73].

The gel was made

by melting 1.8 g agarose in 15.2 ml 5X Running Buffer (200 mM
MOPS, 50 pM sodium acetate, pH 7.0, 10 pM EDTA, pH 8.0) and 60.8
ml ddH20, cooling to 56°C, and adding 9.1 ml formaldehyde, 15.2 ml
5X Running Buffer, and 52.7 ml ddH20.

7.5 pi Ethidium bromide

(lOmg/ml) was added to a final concentration of 0.5 pg/ml.

10 pi

loading buffer (stock solution = 250 pi formamide, 100 pi RNA-Bond
Dye, 80 pi formaldehyde) was added to 10 pg total RNA and loaded
with micropipetting onto the gel immersed in 2 L of IX Running
Buffer.

The gel was electrophoresed at 150 volts for 10 min, and

then at 40 volts for 12 hours.

The gel was then soaked in 10X SSC

for 10 min, marked for orientation, photographed, and allowed to
soak for 20 min more to wash out excess ethidium bromide.

The gel

was inverted onto a sheet of oversized Whatmann's paper, and a
nitrocellulose filter of exact size was placed on top of the gel, with
care taken to avoid air bubbles.

This was covered by 4 sheets of

Whatmann's paper and a 2 inch stack of paper towels cut to exact
size.

A glass plate and weight was placed on top, and RNA transfer to

-

the nitrocellulose filter was allowed for 5 hours, using 20X SSC as the
transfer solution.

The filter was air-dried and baked at 80°C, under

vacuum, for 2 hours.

Preparation of TIMP Probe for Hybridization
The probe used for hybridization was mouse TIMP cDNA (16c8)
kindly provided by Dr. D. Denhardt (University of Western Ontario).
A maxiprep of the plasmid containing the 16c8 TIMP cDNA was
performed.

Cells containing the plasmid DNA were spread onto LB-

agar plates containing Ampicillin and incubated at 37°C overnight.
Two of the colonies were added to 2 ml LB + Amp broth and placed at
37°C for 12 hours, with shaking (325 RPM).

These 2 ml cultures

were added to 500 ml of LB+Amp broth in a 2 L flask, and incubated
at 37°C overnight, with shaking.
400 ml of the culture was placed on ice for 15 min and then
centrifuged at 5000 RPM for 15 min.

The supernatant was discarded

and the pellet was resuspended with vigorous pipetting in 16 ml of
Solution I (3.6 ml 50% glucose solution, 2.5 ml 2 M Tris-HCl, pH 8.0, 4
ml 0.5 M EDTA, pH 8.0, and 189 ml ddH20) and 50 mg of Lysozyme.
This suspension was left at room temperature for 10 min and then
mixed with 32 ml of Solution II (10 ml 20% SDS, 8 ml 5 M sodium
chloride, and 182 ml ddH20), and placed in an ice-H20 bath for 5 min.
16 ml of pre-cooled Solution III (60 ml potassium acetate, 11.5 ml
glacial acetic acid, and 128.5 ml ddH20) was added and placed in iceH20 bath for 5 min.

The mixture was spun at 5000 RPM for 15 min.

The supernatant was filtered through gauze and spun again at 5000
RPM for 15 min.

0.6 volumes of isopropanol was added and left at

-

17

-20°C for 15 min.

The solution was spun at 6000 RPM for 15 min at

0°C, drained well, and the pellet was resuspended in 10 ml TE buffer
(10 mM Tris-HCl, pH 8.0, 1 rnM EDTA, pH 8.0) with Tris-HCl, pH 8.0
added until the pH of the solution was greater than 6.5.
10 g of Cesium chloride was added to the suspension and it was
transferred to a 30 ml ultracentrifuge tube, which was topped-up
with a CsCl:TE solution (1:1 w/v) and 0.5 ml ethidium bromide (10
mg/ml).

This mixture was spun at 48000 RPM for 12 hours at 15°C.

The DNA band was extracted with a 18-gauge needle and transferred
to a 5 ml ultracentrifuge tube.

Ethidium bromide was added and this

solution was spun at 55000 RPM for 12 hours at 15°C.
The DNA band was extracted as before and transferred to a 15
ml Falcon tube.

Ethidium bromide was removed by extracting with

one volume of 90% butanol, vortexing, and discarding the top phase.
This was repeated six times until the DNA solution was clear.

The

solution was placed in a dialysis bag and submerged in 2 L TE with
stirring for 30 min.

This was repeated twice and the OD260/28Q was

checked.

Labeling of TIMP cDNA Probe for Hybridization
5 pg of plasmid DNA containing the mouse TIMP cDNA (16c8)
was linearized by digestion with PvuII at 37°C for 1 hour.
in the polylinker of the plasmid DNA.

PvuII cuts

10 pi of the digest was

electrophoresed on a 1.5% agarose minigel to evaluate efficiency of
digestion.

DNA was radiolabeled by modification of the method of

oligolabeling described by Feinberg & Vogelstein [74].

60 ng of

linearized plasmid DNA containing the mouse TIMP cDNA was added

'

to 32.5 pi ddH20 and placed at 95°C for 5 min, 37°C for 5 min, and
then on ice.

This solution was incubated with 10 pi Oligolabeling

Buffer (-dCTP) [74], 2 pi bovine serum albumin (10 mg/ml), 5 pi 32PdCTP, and 2 U Klenow DNA polymerase I, at room temperature
overnight.

The reaction was stopped with 50 pi STE buffer and

purified through a Sephadex G-50 spun column [73].

The column

was prepared by plugging the tip of a 1 cc syringe with glass wool,
filling with Sephadex G-50 solution, and spinning in a 15 ml Falcon
tube until the G-50 column was compact.
twice with 200 pi of STE, with spinning.

The column was washed
The labeling reaction

mixture was extracted with phenolrchloroform, and the aqueous
phase was run through the column.

The sample was recovered (~100

pi), checked with a Geiger counter, and used for hybridization.

Prehvbridization

and

Hybridization

The baked filter was wetted in 2X SSC and placed into a
hybridization slot containing 15 ml of prehybridization solution (3.75
ml 20X SSC, 7.5 ml formamide, 3.0 ml 50X Denhardt's Solution, 0.5 ml
sodium phosphate, 0.5 ml 20% SDS, and 250 pi salmon sperm DNA
boiled for 10 min) at 42°C for 2 hours.

The prehybridization solution

was poured off, and 15 ml of hybridization solution (3.75 ml 20X SSC,
7.5 ml formamide, 0.5 ml 50X Denhardt's Solution, 0.2 ml sodium
phosphate, 0.5 ml 20% SDS, 3.0 ml Dextran sulfate, and 250 pi salmon
sperm DNA and 100 pi labeled TIMP cDNA boiled for 10 min) was
added, and left at 42°C for 20 hours.

The filter was transferred into

2X SSC to remove extremely loose counts, and washed as follows:
twice in 1 L 2X SSC/0.1% SDS at 42°C for 20 min each, and three

.

times in 0.6X SSC/0.1% SDS at 42°C for 30 min each.

The filter was

placed onto Whatmann's paper, air-dried, covered with Saran wrap,
and exposed to Kodak autoradiography film at -70°C for 48 hours.
The film was developed and the blots of TIMP hybridization were
scanned to determine the density of TIMP expression using a density
scanner in Dr. S. Altman's laboratory (Department of Biology, Yale
University).

RNA isolation from human fibroblasts
Fibroblast cultures were established from abdominal skin
obtained during the incision for aortic reconstruction in six patients
with aneurysm disease, and one control patient with occlusive
disease.

The skin specimens were washed in phosphate buffered

saline (PBS), 70% isopropanol, and again in PBS, then defatted,
minced, placed dermal side down on petri-dishes, and allowed to
dessicate for 45 minutes.

Dulbecco's modified eagles medium

supplanted with 10% fetal bovine serum (Gibco, Grand Island, NY)
and 10,000 U/ml penicillin/streptomycin (Gibco) was then added.
The cells were allowed to reach confluence (approximately one
month), passaged with 0.25% trypsin, and plated onto 150 cm3
dishes.

When confluent, the cells were washed with 10 ml PBS X 2

and 3.5 ml 4 M GIT solution (guanidium isothiocyanate (Boehringer),
20 mM sodium acetate pH 5.2, 0.5% N-lauryl sarcosine, Bmercaptoethanol) was added.

The viscous solution was then drawn

up via a 21-guage needle into a 10 cc syringe and drawn up and
down 4 times.

The GIT solution/cell lysate was layered onto 1.5 ml

of 5.7 M CsCl in ultracentrifuge tubes, and centrifuged in a Beckman

■
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L8-70M at 35000 RPM for 18 hours at 18°C.

The supernatant was

aspirated and the pellet was resuspended in 200 pi TES (10 mM Tris
pH7.4, 5 mM EDTA, 1% SDS).
was performed X 2.

A chloroform/butanol (4:1) extraction

40 pi 3 M sodium acetate and 1 ml 95% EtOH

were added to the final 360 pi RNA/TES.

This was placed at -80°C

for 2 hours, and then centrifuged at 14000 RPM for 30 minutes at
4°C.

360 pi of water was added and 10 pi of this solution, plus 490 pi

water was added to determine OD260/28(r 40 pi of 3 M sodium
acetate and 1 ml 95% EtOH were added, and the RNA was stored at
-80°C as a suspension.

Sequencing of TIMP gene in AAA
Total fibroblast RNA isolated from AAA patient #2 (figure 3,4)
was prepared as above.

Complementary DNA (cDNA) was

transcribed from 2 pg of total RNA in a 50 pi reaction containing 50
mM Tris-HCl, pH 8.3, 75 mM KC1, 10 mM dithiothreitol, 3 mM MgCl2,
500 mM each of all four deoxynucleotides, 2.5 pg random hexamers
(pdN6), 1 U placental ribonuclease inhibitor and 800 U recombinant
Moloney murine leukemia virus reverse transcriptase (Bethesda
Research Labs, Gaithersburg, MD).

Incubation was at 37°C for 1 hour.

Polymerase Chain Reactions fPCR)
Oligonucleotide primers were synthesized by Dr. T. Barnett
(Molecular Diagnostics, Inc., West Haven, CT).

PCR for TIMP cDNA-

specific amplification was performed by incubating 5 pi of cDNA in a
100 pi reaction mix with 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 1.5 mM
MgCl2, 0.001% gelatin, 200 pM each dNTP, 1 pM each TIMP
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oligonucleotide primer, and 25 U/ml AmpliTaq DNA polymerase
(Perkin Elmer/Cetus, Norwalk, CT).

Primer pairs used for

amplification were 5' forward oligo TIMP1
(5'AGATCTAGCGCCCAGAGAGACACCAGAGA3'), 3' reverse oligo TIMP2
(5'GGGATCCGGGTGGACACTGTGCAGGCTTC3'), and internal forward
oligo TIMP3 (5’GGGATCCAAGCCTTAGGGGATGCCGCTGA3'); restriction
endonuclease cleavage sites for Bglll (AGATCT) or BamHI (GGATCC)
are incorporated at the 5' ends of the appropriate oligonucleotide.
Amplification in a Perkin/Elmer thermocycler was for a total of 40
cycles as follows: cycle 1 (94°C, 5 min; 55°C, 2 min; and 72°C, 3 min),
cycles 2 through 39 (94°C, 1 min; 55°C, 2 min; and 72°C, 3 min) and
cycle 40 (94°C, 1 min; 55°C, 2 min; and 72°C, 8 min).

Products of PCR

reaction were analyzed by electrophoresis of 5 pi on 1.5%
agarose/1.5% NuSieve agarose gels.

Cloning and Sequencing of PCR Products
PCR reactions prepared by priming of cDNA with oligos TIMP1
and TIMP3, or with TIMP2 and TIMP3, were extracted by
phenol/chloroform,

ethanol precipitated

and resuspended

for

digestion with restriction endonucleases BamHI and Bgill (TIMP1/3
product) or Bglll alone (TIMP2/3 product), then electrophoresed on
1% LGT (low gelling temperature)-agarose.

Ethidium bromide

staining bands corresponding to TIMP1/TIMP3 products (-700 bp)
and TIMP2/TIMP3 products (-450 bp) were excised, melted with 0.3
M sodium acetate and 0.1 M Tris-HCl, mixed with water-saturated
phenol and cooled on ice.

Separation of agarose and phenol layers

from aqueous was by centrifugation.

DNA in the upper layer was
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precipitated by addition of two volumes of ethanol and frozen in
dry-ice.

Pelleted DNA was resuspended in 5 pi H20.

DNA segments

were then prepared for sequencing by ligation with BamHI-cleaved
Bluescript KS+ plasmid vector DNA (Stratagene, San Diego, CA).
Reactions were 100 ng of cleaved DNA, 2 ng BamHI-cleaved vector
DNA, 10 mM Tris-HCl, pH 7.5, 10 mM DTT, 10 mM MgC12, 2 mM ATP,
and 400 U T4 DNA ligase (New England Biolabs, Beverly, MA) in 15 pi
at 15°C overnight.
competent

Transformation of ligated DNA was into

E. coli DH5-alpha cells spread onto LB-agar plates

containing 75 pi of 2% X-gal and 15 pi of 100 mM IPTG
(isopropylthiogalactoside).

Potential recombinant candidates were

picked from among the white colonies on the plates and grown in 2
ml LB broth at 37°C overnight.
Minipreps of plasmid DNA were performed.

1.4 ml of 2 ml

cultures was pipetted into eppendorf tubes and spun for 2 min.

The

supernatant was discarded and the pellet resuspended in 300 pi
STET buffer (8% sucrose, 5% Triton X100, 50 mM Tris-HCl, pH 8.0, 50
mM EDTA).

25 pi Lysozyme (10 mg/ml) was added to each tube

which were vortexed for 2 min, boiled for 1 min, and spun for 15
min.

200 pi of supernatant was mixed with 230 pi isopropanol,

placed at -20°C for 30 min, and spun for 5 min.

The pellets were

resuspended in 50 pi TE buffer (10 mM Tris-HCl, 8.0, 1 mM EDTA),
extracted with phenol X2, CHC13 XI, and precipitated with 0.3 M
sodium acetate, pH 7.0, and two volumes of ethanol in a dry-ice bath.
Tubes were spun for 10 min and the DNA pellets were washed with
70% ethanol in a speed-vac.

50 pi TE and 1 pi RNAse (10 mg/ml)

were added to each tube, followed by incubation at 70°C, 10 min, and
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37°C, 15 min.

Recombinant clones were determined by digestion of

plasmid DNA at flanking sites with EcoRI/Xbal, since Bglll termini
cannot be excised after ligation to complementary BamHI ends.
Plasmid DNAs demonstrating inserts of the expected sizes (either
-700 or 400 bp) were sequenced in both directions directly from
double-stranded DNA by the dideoxynucleotide method of Sanger et
al, described in [73].

The primers employed for sequencing directly

from Bluescript DNA were T7 and T3 in the presence of 35S-dATP
(Amersham Corp.).

Sequence analysis was performed using the

University of Wisconsin Genetics Computer Group programs.

TIMP expression in AAA
Total fibroblast RNA from six AAA patients and one patient
with occlusive disease was prepared as described above.
aliquots of total RNA from each cell line

15 pg

was electrophoresed in a

1.2% agarose gel containing formaldehyde as described above.

15 pg

of total RNA from a lymphoblast cell line which does not express the
TIMP gene was obtained from Dr. Stefano Martinotti in Dr. A.
Hayday's laboratory (Department of Biology, Yale University) and
used as a negative control (figure 3A,3B, #8).

A second gel was run

with 10 pg aliquots of total RNA from AAA patients (#1, 2, 6, and 7),
the patient with occlusive disease (#5), and total RNA from a normal
human fibroblast cell line donated by Dr. P. Seperack (Miles
Pharmaceuticals, West Haven) which was used as a second positive
control (figure 4A,4B, #9).

RNA was transferred to nitrocellulose

filters, and prehybridized and hybridized at 42°C in prehybridization
and hybridization solutions as previously described.

Blots were

■'

washed to a stringency of 0.1X SSC/0.1% SDS at 42°C, air-dried, and
autoradiographed at -70°C for 36 hours.
The probe used for hybridization was human TIMP cDNA,
generated from total fibroblast RNA from AAA patient #2, and
amplified via PCR, as described earlier.

Bluescript plasmid containing

the PCR product from oligos TIMP 2/TIMP3 was linearized by
digestion with BamHI at 37°C for 1.5 hours.

60 ng of linearized DNA

was radiolabeled and purified as previously described.

■
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Results

Total RNA from rat fibroblasts and smooth muscle cells, and
bovine aortic endothelial cells was probed with mouse TIMP cDNA to
detect TIMP expression in different cell types.

The TIMP gene is

expressed in fibroblasts, smooth muscle cells, and aortic endothelial
cells (figure 1A).

TIMP expression is increased two- to three-fold in

cells exposed to TGF-B (figure IB).
Human TIMP cDNA was generated from total RNA isolated from
dermal fibroblast cell lines of patients with AAA.

TIMP cDNA was

amplified via PCR, cloned into Bluescript KS+ plasmid vector DNA, and
sequenced in both directions directly from dsDNA by the chaintermination dideoxynucleotide method of Sanger et al.

The sequence

of the TIMP cDNA derived from cell line #2 (figure 3,4) was identical
in nucleotide, and expected amino acid sequence (figure 2B) to that
published by Docherty et al [72].
Dermal fibroblasts cultures were established from patients
with AAA and a positive family history for AAA.

Five of the six

patients were male, and ages ranged from 67 years to 77 years.

The

only surviving control cell line (figure 3,4, #5) was established from
an age-matched female patient who underwent abdominal surgery
for occlusive disease.

Total RNA from a normal human fibroblast cell

line was donated by Dr. P. Seperack (Miles Pharmaceuticals, West
Haven) and used as a second positive control (figure 4A,4B, #9).
RNA was probed with human TIMP cDNA to compare
expression in AAA vs. controls.

TIMP

Densitometry studies were

performed in Dr. S. Altman's laboratory (Department of Biology, Yale

.
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University).

TIMP is expressed in the fibroblast cell lines, but not in

equivalent amounts of the lymphoblast cell line (figure 3A,3B).
There is no significant difference in TIMP expression in patients with
AAA compared to patients without AAA (figure 3,4).
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Discussion

The results in figure 1 are consistent with the findings of
Edwards et al that TIMP is expressed in fibroblasts, and there is
increased expression in the presence of TGF-B.

The result most

relevant to this paper is that TIMP is present in smooth muscle cells
and aortic endothelial cells and can be regulated by growth factors.
In order to implicate TIMP in AAA development, it must be present
in the cells most directly affected by AAA formation, and have the
ability to be regulated.

These results show that both these criteria

are met.
Figure 1A shows an abundance of nonspecific binding of the
probe resulting in the bands in the region of TIMP mRNA being less
discernable.

Since the nonspecific binding is confined to the lanes of

transferred RNA, it is most likely secondary to complementary
sequences in the plasmid DNA used to clone the mouse TIMP cDNA
16c8.

The plasmid was only linearized prior to labeling.

The

decreased intensity of the signals in the region of TIMP expression
could also be due to the level of stringency used while washing the
filter.

The TIMP gene has approximately 70% conserved sequences

across species, therefore, a higher level of hybridization would be
expected than was observed.

It is possible that the high

concentration of the cloning plasmid DNA resulted in decreased TIMP
specific labeling.

The TIMP cDNA was ~600 bp, whereas the plasmid

DNA was almost 2000 bp.

It would have been better to cut the TIMP

sequences out of the plasmid to allow a higher concentration of
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labeled TIMP DNA, resulting in more specific hybridization, and a
cleaner northern blot.
Figure 2B shows that the sequence of TIMP cDNA from one
AAA patient is identical to the normal sequence previously
published.

It would be useful to look at the sequence of some of the

other TIMP cDNAs to confirm that there is no sequence change in any
of the cultured AAA cell lines.

Using PCR to amplify the TIMP cDNA

has potential for error since early misincorporation of one or more
bases could be retained and propagated through succeeding cycles of
amplification, resulting in an increased frequency of error products.
The use of Taq DNA Polymerase reduces the possibility of errors
since Taq DNA Polymerase has high fidelity, with a misincorporation
rate/cycle of 2 x 10'4, and only highly complementary substrate
remains as the reaction approaches the temperature at which
catalysis occurs [75].

PCR based on Taq DNA Polymerase represents a

form of "cell-free molecular cloning" that can accomplish
amplification in 3-4 hours which might take days or weeks of
biological growth and biochemical purification [75].
Figures 3 and 4 show no significant difference in TIMP
expression in dermal fibroblasts from AAA patients compared to
patients without AAA.

Evidence of decreased TIMP expression in

AAA would support the hypothesis that decreased TIMP expression
accounts for the observed TIMP protein deficiency in aneurysmal
aorta tissue.

However, the higher level of TIMP expression seen in

the control (figure 3B, #5) is not significant since the amount of
variation is within the accepted range.

Also, when the filter was

probed with a human tubulin gene PCR product (395 bp) to evaluate
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the efficiency of the hybridization technique, the intensities of the
blots showed comparable variation as seen when probed with TIMP.
Thus, the difference observed by densitometry sudies in figure 3B is
not significantly real, and may be a result of better loading of the gel
or better transfer of RNA to the nitrocellulose filter in the case of #5.
Evidence of similar TIMP expression in AAA and nonAAA patients is
confirmed in figure 4B.

Unfortunately, these results are based on

only two controls, and it is not possible to state undoubtedly that
AAA patients do not have down-regulation of TIMP expression.

It

would be helpful to have more normal and nonAAA controls to
confirm these results.
The deficiency of TIMP gene product in AAA which has been
observed [70], may be secondary to loss of elastin, since TIMP is a
matrix-associated protein [76], and there is decreased matrix protein
in AAA [17,24,37].

Another possibility is that TIMP deficiency is

site-specific, and localized to the infrarenal aorta.

Further studies

with aortic smooth muscle cells and in situ hybridization using
abdominal aortic tissue would help to evaluate these possibilities.
Dermal fibroblasts were used in this study because most of the work
on TIMP expression has been done using dermal fibroblasts, and it
would have been useful to detect a systemic defect in AAA disease,
which would facilitate the development of a simple, cost-effective
screening technique.

Also, abdominal aortic smooth muscle cells

have decreased replication potential [3] and

it is difficult to

determine whether findings are primary, or merely secondary
features of AAA.
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Conclusion

Aneurysmal disease is the 13th leading cause of death in the
United States and the incidence of the disease is increasing annually
[5-7].

Rupture of AAA is a life-threatening occurrence with

mortality up to 80% [61].

Several hypotheses have been proposed to

explain AAA development including proteolysis,
biomechanical/physiologic

phenomena,

and

genetic

predisposition.

There is a considerable amount of convincing evidence in support of
proteolytic and genetic phenomena.

It would be useful to discover a

unifying entity between these two hypotheses.

Assignment of TIMP

to the X chromosome raises the possibility that a relative deficiency
of this inhibitor of metalloproteases may be the link between the
increased protease activity and the male preponderance observed in
AAA disease.

Studies describing decreased antiprotease inhibitory

activity [18,19] and decreased TIMP in AAA tissue [70] support this
hypothesis.

It was felt that the apparent low incidence of AAA in

women may be due to a gene dosage effect, where the TIMP gene
escapes inactivation on either X chromosome [36].

Genes have been

sudied at the region on the short arm of the X chromosome where
TIMP has been localized which escape inactivation, and are
expressed from both X chromosomes [77].

Recent work has shown

that there is a 100-fold less transcription of the TIMP gene from the
inactive X chromosome than from the active X suggesting that the
TIMP gene is inactivated on one X chromosome in females, thus
ruling out the gene dosage hypothesis [78].

TIMP is expressed in various cell types (figure 1) including
fibroblasts, smooth muscle and aortic endothelial cells.

TIMP is also

present in skin and corneal fibroblasts, uterine smooth muscle cells,
ovaries, fetal osteoblasts, tendon and cartilage explants, aortic
smooth muscle cells, serum and amniotic fluid [69].

This ubiquitous

nature of TIMP has implicated it as a major factor in the regulation
of connective tissue turnover throughout the body [69].
The presence of a primary defect in the TIMP gene could result
in a defective gene product with decreased inhibitory function, or in
down-regulation of the gene leading to decreased expression and a
deficiency of the inhibitor in tissue.

Detection of such a defect could

be useful to a better understanding of the disease process and
development of a screening test to identify high risk populations,
thus allowing earlier intervention for prevention or elective repair of
AAA.

The present studies do not support the hypothesis that the

deficiency of TIMP in aneurysmal aorta is due to a primary defect in
the gene, since there is no apparent sequence change, and no
significant difference in TIMP transcription in dermal fibroblasts.
The deficiency of TIMP gene product in AAA [70] may be secondary
to loss of elastin, since TIMP is a matrix-associated protein [76], and
there is decreased matrix protein in AAA [17,24,37].

Another

possibility is that TIMP deficiency is site-specific, and localized to the
infrarenal aorta.

Abdominal aortic smooth muscle cells have

decreased replication potential [3] and the effect of factors which
inhibit or degrade TIMP would be potentiated since there is
decreased turnover of cells.

Further studies with aortic smooth

muscle cells and in situ hybridization using abdominal aortic tissue
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may be helpful, although it will be difficult to determine whether
findings are primary, or merely secondary features of AAA.
The decrease in TIMP in AAA tissue may be due to an increase
in neutrophil elastase activity [70].

TIMP can be degraded by

neutrophil elastase and other serine proteases [80], and Cannon [18]
and Cohen [79] have shown that neutrophil elastase activity is
increased and antiproteolytic activity decreasd in AAA.

Thus,

neutrophil elastase may potentiate metalloprotease activity by
inactivation of its inhibitor.

It is possible that aneurysm patients

produce normal concentrations of TIMP that is less biologically
active, i.e., TIMP that is less able to associate with the matrix, less
able to interact with its binding-site, or more susceptible to
degradation.

This phenomena has been reported in cigarette

smokers with and without emphysema, where a normal
concentration and phenotype of alphaj-antiprotease is present, but
antiproteolytic capacity is not [26-28].

Thus, the level of TIMP

expression may be normal, but post-transcriptional or translational
factors may affect TIMP maturity, stability, and/or availability.
TIMP is more soluble in AAA tissue, therefore, the deficiency of
TIMP may be due to increased degradation.
extremes of temperature and pH [81].

TIMP is stable at

It is possible that factors

leading to decreased heat stability of TIMP in aneurysm patients
could result in inactivation, and loss of its inhibitory action.
Kontusaari [58] showed that a mutation leading to synthesis of a less
heat stable procollagen resulted in aneurysm formation in a family.
Mature TIMP has several N-linked glycosylation sites which are
important for function [82].

Deficient or defective glycosylation in

aneurysm patients could result in decreased inhibition of
metalloproteases.

Further studies of the TIMP gene product from

patients with AAA may be useful in resolving these issues.
The etiology of AAA is most likely multifactorial with the
increased propensity for AAA in the infrarenal aorta due to
biomechanical/physiological factors.

Some aortic aneurysms are due

to defects in structural proteins whether as a result of mutations in
the structural genes themselves [58], or in the pathway leading to
formation and turnover of structural proteins, as in the Blotchy
mutation [38-42].

Elastase specific to AAA tissue is inhibited by

copper, and may have increased activity in states of copper
deficiency, which may be genetically controlled.

Specific gene

markers on chromosome 16 are associated with AAA [59].

Certain

haptoglobin phenotypes have been found to accelerate elastolysis by
two- to four-fold in vitro.

It is possible that haptoglobin makes

elastin more susceptible to degradation by binding to it, or there may
be a gene on chromosome 16 that is associated with AAA, and in
linkage equilibrium with the haptoglobin gene.

These findings can

explain proteolysis and the familial tendency for AAA, but does not
account for the apparent male preponderance among patients with
AAA, therefore, this may only account for some AAA.
The genetic basis of AAA formation is still to be determined.

It

is hoped that ultimately a specific gene abnormality or abnormalities
will be identified to permit earlier detection of individuals
predisposed to AAA formation, even prior to AAA development.
Screening tests could then be developed to 1. detect previously
unknown AAA for resection or observation, 2. permit more accurate
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identification of affected and unaffected individuals in pedigrees to
allow a more precise definition of mode of inheritance of
susceptibility to AAA formation so that linkage studies to identify
specific genes involved may be undertaken, and 3. identify a large
enough pool of patients with small AAAs so that the natural history
of AAA development can be studied.

This would allow investigators

to determine factors which contribute to enlargement, and permit
randomized trials of drug therapy to retard or prevent AAA growth.
The genetic predisposition for AAA development is
exacerbated by environmental risk factors such as hypertension,
smoking, and diet.

Patients with AAA should have their

hypertension controlled, and should be encouraged not to smoke.

15

-

adrenergic blockade has been shown to delay the formation of aortic
aneurysms in Blotchy mouse [83] and humans [84], and to decrease
the chance of rupture in turkeys with aneurysmal disease [13,14,45],
Propanolol inhibits development of aneurysms by a direct effect on
collagen cross-linking independent of its effects on heart rate and
blood pressure [45].

Therefore, treatment with 15-blockers may have

a two-fold effect: contolling hypertension and slowing aneurysm
formation.

Calcium-channel blockade has also been suggested to

slow the progression of the disease in patients with small AAA [85].
Patients with AAA disease and their first-degree relatives should be
screened by abdominal ultrasound, at least annually, to monitor
aortic dilatation.

Aneurysm size greater than 5 cm correlates with a

clinically significant risk of rupture, therefore, elective repair should
be considered if there is rapid expansion or increase in size to 5 cm
or greater [35,86].
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Figure 1 A. TIMP Expression in Different Cell Types
1 0 ng of total RNA from rat fibroblasts (1,2), rat smooth muscle
cells (3,4), and bovine aortic endothelial cells (5,6) were
electrophoresed in an agarose gel containing formaldehyde,
transferred to a nitrocellulose filter, and probed with mouse TIMP
cDNA. Northern blot shows TIMP expression in different cell types,
and the effect of TGF-R on TIMP expression. (TIMP cDNA ~ 0.7 kb).
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Figure 1 B. TIMP Expression in Different Cell Types
Densitometry was performed on the northern blot shown in
figure 1 A to evaluate the effect of TGF-p on TIMP expression in
rat fibroblasts (1,2), rat smooth muscle cells (3,4), and bovine
aortic endothelial cells (5,6).
(U = arbitrary densitometry units)
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XLQDGLLHITTCSFVAPWNS

420

421

ctgagcttagctcagcgccggggcttcaccaagacctacactgttggctgtgaggaatgc
lslaqrrgftktytvgceec

480

481

acagtgtttccctgtttatccatcccctgcaaactgcagagtggcactcattgcttgtgg
TVFPCLS1PCKLQSGTHCLW

540

541

acggaccagctcctccaaggctctgaaaagggcttccagtcocgtcaccttgcetgcctg
tdqilqgsbkgfqsrhlacl

600

601

cctcgggagccagggctgtgcacctggcagtccctgcggtcccagatagcctgaatcctg
PREPGLCTWQSLRSQ1A

660

661

cccggagtggaagctgaagcctgcacagtgtccaccc

697

TIMP2

Figure

2A. Oligonucleotide

Primer

Locations

for

PCR

TIMP1 (5' agatctagcgcccagagagacaccagaga 3'), TIMP2
(5' g&gatccgggtggacactgtgcaggcttc 3'), TIMP3
(5' gggatccaagccttaggggatgccgctga 3'); Bglll (AGATCT) and BamHI
(GGATCC) cleavage sites were incorporated at the 5' ends of the
oligos.

TIMP cDNA generated from human total fibroblast RNA from

a patient with AAA (figure 3, 4, #2) was mixed with pairs of these
primers for TIMP cDNA specific amplification.

38

1

agcgcccagagagacaccagagadcccaccatggccccctttgagcccctggcttctggc
NAPFEPLA80

50

61

atcctgttgttgctgtggctgatagcccccagcagggcctgcacctgtgtcccaccccac
ILLLLKLIAP8PACTCVPPH

120

121

ccacagacggccttctgcaattccgacctcgtcatcagggccaagttcgtggggacacca
PQTAPCNSDLVI .RAKfVOTP

180

181

gaagtcaaccagaccaccttataccagcgttatgagatcaagatgaccaagatgtataaa
EVNQTTIYQRYBI
KMTKMYK

240

241

gggttccaagccttaggggatgccgctgacatccggttcgtctacacccccgccatggag
GFQALGDAADXRrVYTPAMB

300

301

agtgtctgcggatacttccacaggtcccacaaccgcagcgaggagtttctcattgctgga
svcgyfhrshnrseefliag

360

361

aaactgcaggatggactcttgcacatcactacctgcagtttcgtggctccctggaacagc
KLQDGLLHX
TTCS
FVAPWN5

420

421

ctgagcttagotcagcgccggggcttcaccaagacctacactgttggctgtgaggaatgc
lslaqrrgftktytvgcbec

480

481

acagtgtttccctgtttatccatcccctgcaaactgcagagtggcactcattgcttgtgg
TVFPCLSIPCKLQSGTHCLW

540

541

acggaccagctcctccaaggctctgaaaagggcttccagtccogtcaccttgcctgcctg
tdqllqgsekgfqsrhlacl

600

601

cctcgggagccagggctgtgcacctggcagtccctgcggtcccagatagcctgaatcctg
PREPGLCTWQSLRSQIA

660

661

cccggagtggaagctgaagcctgcacagtgtccaccc

Figure

2B. Sequence of TIMP cDNA

697

from

AAA

Patient

PCR products from TIMP cDNA primed with oligos TIMP1 & TIMP3,
or with TIMP2 & TIMP3 were ligated with BamHI-cleaved Bluescript
KS+ plasmid vector DNA.

Sequencing was performed in both

directions directly from double-stranded DNA by the
dideoxynucleotide method of Sanger et al.

The sequence is identical

in nucleotide and amino acid sequence to that published by Docherty
et al as the normal sequence.

■

-
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2 kb

-

Figure 3A. TIMP Expression in AAA
15 Mg of total dermal fibroblast RNA from six patients
with AAA (1,2,3,4,6,7) and one patient with occlucive
disease (5), and 15 pg of total lymphoblast RNA (8), were
electrophoresed, transferred to a nitrocellulose filter,
and probed with human TIMP cDNA. Northern blot shows
TIMP expression in AAA and nonAAA dermal fibroblasts.
TIMP is not expressed in the lymphoblast cell line. (TIMP
cDNA * 0.7 kb).
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CELL LINES
Figure 3B. TIMP Expression in AAA
Densitometry was performed on the northern
blot shown in figure 3A, to compare TIMP expression in
AAA patients (1,2,3,4,6,7) with a nonAAA control (5). Cell
line ^8 is a non-TIMP expressing control.
(U = arbitrary densitometry units)

41

•

* •

•

I
Mi

2 kb

1 kb

TIMP

12

5

6

7

9
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Figure 4A. TIMP Expression in AAA

10 ng of total dermal fibroblast RNA from four patients
with AAA (1,2,6,7), one patient with occlusive disease (5),
and one normal patient (9) were electrophoresed,
transferred to a nitrocellulose filter, and probed with
human TIMP cDNA. Northern blot shows TIMP expression
in AAA and nonAAA dermal fibroblasts. (TIMP cDNA ~ 0.7 kb)
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CELL LINES
x x
% \
X

X

nonAAA

Figure 4B. TIMP Expression in AAA

Densitometry was performed on the northern blot shown
in figure 4A, to compare TIMP expression in AAA
patients (1,2,6,7), with two nonAAA controls: a patient
with occlusive disease (5), and a normal patient (9).
(U = arbitrary densitometry units)
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